Articles tagged “accor”

The hotel giant is quietly tip-toeing its way across Europe, but a hospitality slant may prove to be a weakness rather than a strength.

It’s hard to get a true sense of what future business travel demand will look like until international borders reopen and people can return to the office. But it is time to temper the optimism on any significant recovery happening by the end of the year. CEOs seem to finally get this.

Hoteliers will need to crack new metrics like desk occupancy, pricing plans and even social media credibility to help any co-working venture succeed.

WeWork and IWG will vie for an “asset light” future to recover after the pandemic. And with that, branding becomes even more important in the world of work.

In Skift's top travel stories this week, IHG is launching its 17th brand, global consultancies will cut business travel spend, Oyo edged toward an initial public offering, and British Airways' parent grew its startup accelerator during the pandemic.

Accor has plenty of opportunities to transform itself into more of a lifestyle brand, but every one of its competitors is playing this strategy to some degree. Finding a way to stand out is easier said than done.

If Accor can go from billion-dollar losses to profitability in a matter of months, Marriott shareholders should expect plenty of financial gains and optimism on Tuesday's earnings call.

It’s a little early to call this a rebound, but Accor finally has some wind in its sails as far as recovery numbers go. Now it just needs to hold onto some level of the momentum heading into the fall.

In this video, we hear from Brune Poirson, chief sustainability officer of Accor Group, in discussion with Matt Heidkamp, head of creative strategy at Skift, on how hotels can create lasting positive social impact in travel’s new era.

Profitability is possible, but there won’t be massive financial windfalls to report this week. Investors will still expect at least some sign the leisure-led recovery is benefitting these global hotel companies — especially amid the rise of new variants.